HPA047192

antibody from Atlas Antibodies

Targeting: CLCA2 CLCRG2

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA047192

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA047192, RRID:AB_2679977

Product name

Anti-CLCA2

Antibody type

Polyclonal

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Antigen sequence

EELTLSWTAPGEDFDQGQATSYEIRMSKSLQNIQD
DFNNAILVNTSKRNPQQAGIREIFTFSPQISTNGP
EHQPNGETHESHRIYVAIRAMDRNSLQSAVSNIAQ
APLFIPPNSDPVPARDYLILKGVLTAMGL


Isotype

IgG

Vial size

100 µl

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

References

Submitted references

Transport of CLCA2 to the nucleus by extracellular vesicles controls keratinocyte survival and migration

Seltmann K, Hettich B, Abele S, Gurri S, Mantella V, Leroux J, Werner S
Journal of Extracellular Vesicles 2024;13(4)

---

CLCA2: A Potential Guardian against Premature Senescence and Skin Aging

Guerrero-Navarro L, Martic I, Ploner C, Jansen-Dürr P, Cavinato M
Biomedicines 2024;12(3):592

---

CLCA2 suppresses the proliferation, migration and invasion of cervical cancer

Zhang P, Lin Y, Liu Y
Experimental and Therapeutic Medicine 2021;22(1)

---

Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling

Qiang Y, Li C, Sun R, Zheng L, Peng L, Yang J, Meng D, Lang Y, Mei Y, Xie P, Xu L, Cao Y, Wei W, Cao L, Hu H, Yang Q, Luo D, Liang Y, Huang B, Qian C
Journal of Experimental & Clinical Cancer Research 2018;37(1)